Jose Mario Bello Pineda

8PUBLICATIONS
74CO-AUTHORS
Molecular targetsInnate immunityHaematological tumoursMedical infection agents (incl. prions)Integrable systems (classical and quantum)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 26, 2026
Oncogenic SF3B1 mutations alter the splicing of mRNA noncoding regions to induce a novel therapeutic vulnerability.

Michal Sekrecki, Agata Sekrecka, Rohan R Lattupally

|Nov 07, 2025
Intratumoral Three-Cell-Type Clusters Are a Conserved Feature of Endogenous Antitumor Immunity.

Sheela R Damle, Jason A Carter, Kristin E Goodsell

|Feb 24, 2025
RBM10 loss promotes metastases by aberrant splicing of cytoskeletal and extracellular matrix mRNAs.

Gnana P Krishnamoorthy, Anthony R Glover, Brian R Untch

|Jun 03, 2024
DUX4 is a common driver of immune evasion and immunotherapy failure in metastatic cancers.

Jose Mario Bello Pineda, Robert K Bradley

|Jul 28, 2023
DUX4 is a common driver of immune evasion and immunotherapy failure in metastatic cancers.

Jose Mario Bello Pineda, Robert K Bradley

|Feb 02, 2021
Convergent organization of aberrant MYB complex controls oncogenic gene expression in acute myeloid leukemia.

Sumiko Takao, Lauren Forbes, Masahiro Uni

Pageof 2

Frequent Collaborators

4 joint publications

Robert K Bradley

2 joint publications

Wenying Shou

2 joint publications

Samuel Frederick Mock Hart

1 joint publications

Xiaoyu Zhang